Tuberculosis, Multidrug-Resistant

"Tuberculosis, Multidrug-Resistant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.

Descriptor ID	D018088
MeSH Number(s)	C01.252.410.040.552.846.775
Concept/Terms	Tuberculosis, Multidrug-Resistant Tuberculosis, Multidrug-Resistant Multidrug-Resistant Tuberculosis Tuberculosis, Multidrug Resistant Tuberculosis, MDR MDR Tuberculosis Tuberculosis, Multi-Drug Resistant Multi-Drug Resistant Tuberculosis Tuberculosis, Multi Drug Resistant Tuberculosis, Drug-Resistant Tuberculosis, Drug-Resistant Drug-Resistant Tuberculosis Tuberculosis, Drug Resistant

Below are MeSH descriptors whose meaning is more general than "Tuberculosis, Multidrug-Resistant".

Diseases [C]
Bacterial Infections and Mycoses [C01]
Bacterial Infections [C01.252]
Gram-Positive Bacterial Infections [C01.252.410]
Actinomycetales Infections [C01.252.410.040]
Mycobacterium Infections [C01.252.410.040.552]
Tuberculosis [C01.252.410.040.552.846]
Tuberculosis, Multidrug-Resistant [C01.252.410.040.552.846.775]

Below are MeSH descriptors whose meaning is more specific than "Tuberculosis, Multidrug-Resistant".

Tuberculosis, Multidrug-Resistant
Extensively Drug-Resistant Tuberculosis

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Tuberculosis, Multidrug-Resistant" by people in this website by year, and whether "Tuberculosis, Multidrug-Resistant" was a major or minor topic of these publications.

Bar chart showing 14 publications over 10 distinct years, with a maximum of 3 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2009	1	0	1
2010	1	0	1
2011	1	0	1
2012	1	0	1
2013	1	0	1
2014	1	0	1
2015	0	2	2
2019	2	1	3
2022	1	0	1
2023	2	0	2

Below are the most recent publications written about "Tuberculosis, Multidrug-Resistant" by people in Profiles.

Gupta RK, Anthwal D, Bhalla M, Tyagi JS, Choudhary S, Haldar S. Direct Detection of Fluoroquinolone Resistance in Sputum Samples from Tuberculosis Patients by High Resolution Melt Curve Analysis. Curr Microbiol. 2023 Dec 02; 81(1):27.

View in: PubMed
Moe S, Rekart ML, Hernandez D, Sholpan A, Ismailov A, Oluya M, Bayniyazova A, Zinaida T, Nargiza P, Gomez-Restrepo C, Sitali N, Sinha A. Primary bedaquiline resistance in Karakalpakstan, Uzbekistan. Int J Tuberc Lung Dis. 2023 05 01; 27(5):381-386.

View in: PubMed
Anthwal D, Jamwal S, Gupta RK, Singhal R, Verma AK, Bhalla M, Myneedu VP, Sarin R, Choudhary S, Tyagi JS, Haldar S. Direct Molecular Detection of Drug-Resistant Tuberculosis from Transported Bio-Safe Dried Sputum on Filter-Paper. Curr Microbiol. 2022 Feb 17; 79(4):110.

View in: PubMed
Irfan M, Idrees F, Jabeen K, Zubairi ABS, Butt S, Hasan R. Accuracy of genotype MTBDRplus line probe assay in patients with tuberculous pleural effusion: comparison with clinical and culture based diagnosis. Infect Dis (Lond). 2020 04; 52(4):235-241.

View in: PubMed
Anthwal D, Lavania S, Gupta RK, Verma A, Myneedu VP, Sharma PP, Verma H, Malhotra V, Gupta A, Gupta NK, Sarin R, Haldar S, Tyagi JS. Development and evaluation of novel bio-safe filter paper-based kits for sputum microscopy and transport to directly detect Mycobacterium tuberculosis and associated drug resistance. PLoS One. 2019; 14(8):e0220967.

View in: PubMed
Irfan S, Rao N, Irfan M, Iftikhar I, Azizullah Z, Jabeen K, Hasan R. Utility of the microcolony method for evaluation of multidrug-resistant tuberculosis patients in Karachi, Pakistan. Int J Tuberc Lung Dis. 2019 07 01; 23(7):838-843.

View in: PubMed
Jabeen K, Shakoor S, Hasan R. Fluoroquinolone-resistant tuberculosis: implications in settings with weak healthcare systems. Int J Infect Dis. 2015 Mar; 32:118-23.

View in: PubMed
Mirtskhulava V, Whitaker JA, Kipiani M, Harris DA, Tabagari N, Owen-Smith AA, Kempker RR, Blumberg HM. Determinants of tuberculosis infection control-related behaviors among healthcare workers in the country of Georgia. Infect Control Hosp Epidemiol. 2015 May; 36(5):522-8.

View in: PubMed
Seaworth BJ, Armitige LY, Aronson NE, Hoft DF, Fleenor ME, Gardner AF, Harris DA, Stricof RL, Nardell EA. Multidrug-resistant tuberculosis. Recommendations for reducing risk during travel for healthcare and humanitarian work. Ann Am Thorac Soc. 2014 Mar; 11(3):286-95.

View in: PubMed
Ahmed I, Jabeen K, Inayat R, Hasan R. Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate. Antimicrob Agents Chemother. 2013 Jun; 57(6):2522-5.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement